Login / Register

Did the DEA Just Kick Open the Door for the Pharmaceuticalization of Pot?

While much ink has been spilled over the last few days regarding DEA’s refusal to recognize marijuana as a medicine and its unwillingness to reclassify it under federal law, far less attention has been paid to a separate decision by the agency to create, for the first time, a “clear legal pathway” for pharmaceutical companies to engage in cannabis-specific “drug product development.” Read more »

Comments are closed.